Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.
Exogenus Therapeutics's investors include EIC Accelerator, EISMEA, Caixa Capital, maze impact, 3xP Global.
Exogenus Therapeutics is headquartered in Cantanhede, Portugal.
Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.
Exogenus Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exogenus Therapeutics — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/exogenus-therapeutics. Accessed August 13, 2026.
VCBacked. (2026). Exogenus Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/exogenus-therapeutics
{{cite web |title=Exogenus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/exogenus-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated